<DOC>
	<DOCNO>NCT02797210</DOCNO>
	<brief_summary>This trial compare efficacy active inhibitory OFC-rTMS sham OFC-rTMS major depression . The trial include structural functional MRI , EEG , behavioral measure obtain , , treatment .</brief_summary>
	<brief_title>Examining Efficacy Orbitofrontal Cortex rTMS Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>1. outpatient 2. voluntary competent consent treatment 3. MiniInternational Neuropsychiatric Interview ( MINI ) confirm diagnosis major depressive disorder ( MDD ) , single recurrent 4. age 18 65 5. fail achieve clinical response adequate dose antidepressant base Antidepressant Treatment History Form ( ATHF ) score &gt; 3 current 6. score &gt; 18 HAMD17 7. increase initiation psychotropic medication 4 week prior screen 8. able adhere treatment schedule 9 . Pass TMS adult safetyscreening ( TASS ) questionnaire 10. normal thyroid function base prestudy blood work . 1. MINIInternational Neuropsychiatric ( MINI ) confirm diagnosis substance dependence abuse within last 3 month 2. concomitant major unstable medical illness , cardiac pacemaker implant medication pump 3. active suicidal intent 4. pregnant 5. lifetime MiniInternational Neuropsychiatric Interview ( MINI ) diagnosis bipolar I II disorder , schizophrenia , schizoaffective disorder , schizophreniform disorder , delusional disorder , current psychotic symptom 6. MINI diagnosis obsessive compulsive disorder , posttraumatic stress disorder ( current within last year ) , anxiety disorder ( generalize anxiety disorder , social anxiety disorder , panic disorder ) , dysthymia , assess study investigator primary causing great impairment MDD 7. diagnosis personality disorder , assess study investigator primary causing great impairment MDD 8. fail course electroconvulsive therapy ( ECT ) current episode previous episode 9. significant neurological disorder insult include , limited : condition likely associate increase intracranial pressure , space occupy brain lesion , history seizure except therapeutically induced ECT , cerebral aneurysm , Parkinson 's disease , Huntington 's chorea , multiple sclerosis , significant head trauma loss consciousness great equal 5 minute 10. intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) metal object within near head , exclude mouth , safely remove 11. participate psychotherapy , must stable treatment least 3 month prior entry study , anticipation change frequency therapeutic session , therapeutic focus duration study 12. clinically significant laboratory abnormality , opinion study investigator 13. currently ( last 4 week ) take lorazepam 2 mg daily ( equivalent ) dose anticonvulsant due potential limit rTMS efficacy 14. noncorrectable clinically significant sensory impairment ( i.e. , hear well enough cooperate interview ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>